Clinical Trial Update: Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"

View source ↗

Summary

This clinical trial update reports the completed results of an all-case investigation evaluating Copaxone (glatiramer acetate) subcutaneous injections for preve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)

Snippet

Sponsor: Teva Takeda Pharma Ltd. | Conditions: Multiple Sclerosis | Status: COMPLETED